# Podimetrics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/podimetrics

- Industry: Medical Devices & Equipment
- Headquarters: Somerville, US
- Website: www.podimetrics.com
- Total disclosed funding: $72M
- Latest round: Series C (Dec 1, 2021)
- Investors on record: 6

## About

Podimetrics, Inc., based in the U.S., focuses on diabetes care through innovative technology, offering solutions designed to monitor and improve diabetic foot health for high-risk individuals.Podimetrics, Inc. provides a diabetes virtual care solution through its flagship product, the SmartMat™, which was founded in 2011 in Somerville, US. The company was co-founded by David Linders and Jon Bloom, with Jon Bloom currently serving as CEO. In November 2022, Podimetrics raised USD 25 mn in VENTURE DEBT funding from CIBC Innovation Banking, contributing to a total of USD 44.78 mn raised over eight funding rounds.Podimetrics offers a comprehensive diabetes virtual care solution primarily centered around its flagship product, the SmartMat™. This device employs clinically validated technology to monitor diabetic foot health and provide personalized support for high-risk individuals living with diabetes. Users can step on the SmartMat for just 20 seconds daily, facilitating early detection of inflammation and potential complications. The service is designed to empower patients to prevent serious health issues, reduce hospitalizations, and improve overall quality of life, primarily serving payors, providers, employers, and patients across the United States.Podimetrics generates revenue through partnerships with healthcare payors and providers, offering their SmartMat service as part of a comprehensive care strategy for managing diabetes. Their revenue model is structured around B2B relationships, where healthcare organizations integrate Podimetrics’ technology into their care offerings to enhance patient outcomes and reduce costs associated with diabetes complications. These transactions typically involve contracts with health plans and provider groups, with pricing structures encompassing subscription models or contractual agreements.In November 2022, Podimetrics raised USD 25 mn in VENTURE DEBT funding, which will be used to support its business growth and expand commercial operations. The company is focused on enhancing its product offerings and may explore further geographical expansion to reach underserved markets. Specific details on upcoming new products or targeted regions for expansion have not been disclosed.

## Funding rounds

- Series C, Dec 1, 2021, $45M — Polaris Partners, SV Health Investors, Scientific Health Development, D1 Capital Partners
- Series B, Aug 19, 2020, $11M — Polaris Partners, Norwich Ventures, Rock Health, Scientific Health Development
- Series B, May 9, 2019, $13M — Norwich Ventures, Rock Health, Scientific Health Development
- Series A, Mar 28, 2013, $1M — Norwich Ventures
- Series A, Oct 1, 2012, $1.5M — Norwich Ventures

## Investors

- Norwich Ventures (https://capitalatlas.ai/funds/norwich-ventures) — Series A, Series B
- Rock Health (https://capitalatlas.ai/funds/rock-health) — Series B
- Scientific Health Development (https://capitalatlas.ai/funds/scientific-health-development) — Series B, Series C
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series B, Series C
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series C
- D1 Capital Partners (https://capitalatlas.ai/funds/d1-capital-partners) — Series C